Frontlight ResearchEarly access
Trial site
South Texas Accelerated Research Therapeutics, LLC
- 6running trials
- 4closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Lung cancer6 trials
- Head and neck cancer4 trials
- Pancreatic cancer4 trials
- Colorectal cancer3 trials
- Endometrial cancer3 trials
- Gastric and oesophageal cancer3 trials
- Liver and biliary tract cancer3 trials
- Glioblastoma2 trials
- Ovarian cancer2 trials
- Prostate cancer2 trials
- Sarcoma2 trials
- Triple-negative breast cancer2 trials
- and 6 more
- Phase
- Phase 16 trials
- Phase 1/23 trials
- Status
- Recruiting4 trials
- Active, not recruiting2 trials
- Completed2 trials
- Terminated2 trials
- Lead sponsor
- Seagen, a wholly owned subsidiary of Pfizer3 trials
- Eli Lilly and Company1 trial
- Frontier Medicines Corporation1 trial
- Molecular Templates, Inc.1 trial
- Parabilis Medicines, Inc.1 trial
- and 3 more
Running trials
Recruiting
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Recruiting
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Recruiting
Recruiting
Active, not recruiting
Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
- Colorectal cancer2 recruiting
- Endometrial cancer2 recruiting
- Gastric and oesophageal cancer2 recruiting
- Liver and biliary tract cancer2 recruiting
- Pancreatic cancer2 recruiting
- Head and neck cancer1 recruiting
- Prostate cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026